Related Experiment Video
Updated: Apr 22, 2026
03:20
Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
Published on: September 22, 2023
2.7K
Parkinson's disease in the limelight
1Thomson Reuters, Barcelona, Spain. scientific.prousjournals@thomsonreuters.com.
Drugs of Today (Barcelona, Spain : 1998)
|October 15, 2014
Summary
This review covers Parkinson's disease therapies, acknowledging the Lasker Award winners. It discusses current treatments, their limitations, and the ongoing search for better diagnostics and cures for Parkinson's disease.
Area of Science:
- Neurology
- Medical Research
Background:
- Parkinson's disease therapy has advanced, with numerous drugs and deep brain stimulation available.
- Despite current treatments, many Parkinson's patients experience inadequate symptom control or breakthrough symptoms.
- Parkinson's disease remains ultimately incurable, highlighting the need for novel therapeutic strategies.
Purpose of the Study:
- To review current therapeutic options for Parkinson's disease.
- To explore emerging biomarkers and novel diagnostic approaches for Parkinson's disease.
- To provide an overview of the challenges and future directions in Parkinson's disease treatment.
Main Methods:
- Literature review of existing Parkinson's disease therapies.
- Analysis of current pharmacological and non-pharmacological treatment approaches.
- Examination of diagnostic tools and biomarkers for Parkinson's disease.
Main Results:
- Levodopa remains a gold standard, but its efficacy is limited for some patients.
- Non-pharmacological treatments like deep brain stimulation offer alternatives but do not provide a cure.
- Significant unmet needs persist in managing Parkinson's disease symptoms and progression.
Conclusions:
- Current Parkinson's disease treatments offer symptomatic relief but do not halt disease progression.
- Development of novel diagnostics and biomarkers is crucial for improved patient management.
- Continued research into innovative therapies is essential to address the incurable nature of Parkinson's disease.
More Related Videos
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
2.1K
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
3.6K
Related Concept Videos
01:15Parkinson's Disease: Overview
2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
01:24Parkinson Disease l: Introduction
6
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
6
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:24Parkinson Disease ll: Pathophysiology
11
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
11
01:37Neural Regulation
34.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.5K
01:11Alterations in Muscle Tone lll
19
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
19